Literature DB >> 12841305

Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation.

Nagi S El Saghir1, Ali I Shamseddine, Fady Geara, Kamal Bikhazi, Boushra Rahal, Ziad M K Salem, Ali Taher, Ayman Tawil, Ziad El Khatib, Jaber Abbas, Mukbil Hourani, Moheiddine Seoud.   

Abstract

BACKGROUND: Breast cancer is the most common cancer in Lebanese women. Lebanon has no national cancer registry and the American University of Beirut Medical Center (AUBMC) is one of the largest hospitals in Lebanon and has a fully operational cancer registry. Earlier studies showed that it sees about one third of all cancer cases in Lebanon.
METHODS: All female breast cancer patients recorded at AUBMC between 1983 and 2000 were evaluated. We used the sex-specific age distribution of 1995 Lebanese Population and Housing Survey to estimate the age-specific incidence of breast cancer in Lebanon. The results were calculated as number and proportion of cases, 10-year age-specific incidence rates, crude rates and age standardized rates (ASR) per 100,000 population. The ASR per 100,000 population was estimated by the direct method with the use of the World Standard Population.
RESULTS: Between 1983 and 2000, there were a total of 16421 cancers of which 8007 were in women. There were 2673 female breast cancers, averaging 148 cases per year (Range:94-202). Almost half of cases (49.1%) were in women below the age of fifty. The mean age was:49.8 years +/- 13.9 years. Ten-year age groups distribution showed that 4.7% were below 30 years of age, 16.1% were 30-39 years, 28.3% were 40-49 years, 26.3% were 50-59 years, 16.9 % were 60-69 years, 6.1% were 70-79 years and 1.6% were 80 years of age or older. Twenty-two patients (0.9 %) had their age missing in the records. Overall ASR was 30.6, for a crude rate of 27.7. Age adjusted incidence rate had its peak in women aged 50-59, followed by women 40-49 then 60-69 with values of 96.3, 79.9 and 77.4 per 100,000 respectively. We also noted 19 male breast cancer cases corresponding to 0.7% of the 2692 combined total.
CONCLUSIONS: The percentage of women with breast cancer in Lebanon seen at AUBMC in pre-menopausal and younger-aged groups is higher than those reported from western countries. Our results emphasize the need to search for possible environmental, lifestyle and/or genetic risk factors in Lebanon. Our study also shows the importance of implementing early detection and screening programs which, along with high quality mammography and medical care, can have a positive impact on survival, especially in younger-aged women.

Entities:  

Mesh:

Year:  2002        PMID: 12841305

Source DB:  PubMed          Journal:  J Med Liban        ISSN: 0023-9852


  17 in total

1.  Triple-negative breast cancer in Lebanon: a case series.

Authors:  Marwan Ghosn; Carla Hajj; Joseph Kattan; Fadi Farhat; Fadi El Karak; Fadi Nasr; Gerard Abadjian; Georges Chahine
Journal:  Oncologist       Date:  2011-10-21

2.  Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

Authors:  Mohammed S Fayaz; Mustafa S El-Sherify; Amany El-Basmy; Sadeq A Zlouf; Nashwa Nazmy; Thomas George; Susan Samir; Gerges Attia; Heba Eissa
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-26

3.  Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.

Authors:  Sharon Hensley Alford; Kendra Schwartz; Amr Soliman; Christine Cole Johnson; Stephen B Gruber; Sofia D Merajver
Journal:  Breast Cancer Res Treat       Date:  2008-04-15       Impact factor: 4.872

4.  Hormone receptor status in breast cancer and its relation to age and other prognostic factors.

Authors:  Ali Pourzand; M Bassir A Fakhree; Shahryar Hashemzadeh; Monireh Halimi; Amir Daryani
Journal:  Breast Cancer (Auckl)       Date:  2011-05-18

5.  Effects of young age at presentation on survival in breast cancer.

Authors:  Nagi S El Saghir; Muhieddine Seoud; Mazen K Khalil; Maya Charafeddine; Ziad K Salem; Fady B Geara; Ali I Shamseddine
Journal:  BMC Cancer       Date:  2006-07-20       Impact factor: 4.430

6.  Outcome of Breast Cancer Patients Treated outside of Clinical Trials.

Authors:  Nagi S El Saghir; Hussein A Assi; Sara M Jaber; Katia E Khoury; Zahi Nachef; Hana F Mikdashi; Nadine S El-Asmar; Toufic A Eid
Journal:  J Cancer       Date:  2014-06-03       Impact factor: 4.207

7.  Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients.

Authors:  Alain Mina; Hind Rafei; Maya Khalil; Yasmine Hassoun; Zeina Nasser; Arafat Tfayli
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

8.  Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia.

Authors:  Riyaz Bhikoo; Sanket Srinivasa; Tzu-Chieh Yu; David Moss; Andrew G Hill
Journal:  Cancers (Basel)       Date:  2011-05-13       Impact factor: 6.639

9.  Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america.

Authors:  Riyaz Bhikoo; Sanket Srinivasa; Tzu-Chieh Yu; David Moss; Andrew G Hill
Journal:  Cancers (Basel)       Date:  2011-05-13       Impact factor: 6.639

10.  Stage at diagnosis and delay in seeking medical care among women with breast cancer, delhi, India.

Authors:  Sedigheh Pakseresht; Gopal Krishna Ingle; Suneela Garg; Nahid Sarafraz
Journal:  Iran Red Crescent Med J       Date:  2014-12-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.